Skip to main content
SpringerLink
Log in

Hypoestrogenism and Estrogen Replacement Therapy in Women Suffering from Schizophrenia

  • Chapter
Estrogen Effects in Psychiatric Disorders

  • 806 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albus M, Maier W (1995) Lack of gender differences in age at onset in familial schizophrenia. Schizophr Res 18: 51–57

    Article  PubMed  CAS  Google Scholar 

  • Angermeyer MC, Kühn L (1988) Gender differences in age at onset of schizophrenia. An overview. Eur Arch Psychiatry Neurol Sci 237: 351–364

    Article  PubMed  CAS  Google Scholar 

  • Battey R (1876) Extirpation of the functionally active ovaries for the remedy of otherwise incurable diseases. Trans Am Gynecol Soc 1: 101–120

    Google Scholar 

  • Beck AT, Steer RA (1987) Beck depression inventory — Manual. San Antonio, The Psychological Corporation

    Google Scholar 

  • Behl C (2001) Estrogens — mystery drug for the brain. The neuroprotective activities of the female sex hormone. Springer, Wien New York

    Google Scholar 

  • Bergemann N, Jaggy S, Maier S, Kaiser D, Auler B, Parzer P, Resch F, Mundt Ch (2001) Estrogens effects on neuropsychological performance in schizophrenic women. Arch Women Ment Health 3(Suppl 2): 20–21

    Google Scholar 

  • Bergemann N, Mundt Ch, Resch F, Parzer P, Runnebaum B (1996) The hypoestrogenism hypothesis in female schizophrenia: preliminary hormone screening results. Eur Psychiatry 11(Suppl 4): 403

    Google Scholar 

  • Bergemann N, Mundt Ch, Parzer P, Jannakos I, Nagl I, Salbach B, Klinga K, Runnebaum B, Resch F (2004a) Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsy-chotics. Schizophr Res (in press)

    Google Scholar 

  • Bergemann N, Mundt Ch, Parzer P, Pakrasi M, Eckstein-Mannsperger U, Haisch S, Salbach B, Klinga K, Runnebaum B, Resch F (2004b) No additional effect of estrogen as an adjuvant therapy to antipsychotics for relapse prevention on the psychopathology and the course of illness in women with schizophrenia: results of a placebo-controlled double-blind study (submitted)

    Google Scholar 

  • Bergemann N, Parzer P, Nagl I, Salbach B, Runnebaum B, Mundt Ch, Resch F (2002) Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Arch Women Ment Health 5: 119–126

    PubMed  CAS  Google Scholar 

  • Bleuler E (1943) Die spätschizophrenen Krankheitsbilder. Neurologie 15: 259–290

    Google Scholar 

  • Brockington IF, Kelly A, Hall P, Deakin W (1988) Premenstrual relapse of puerperal psychosis. J Affect Disord 14: 287–292

    Article  PubMed  CAS  Google Scholar 

  • Burger G (1984) Nerven-und Geisteskrankheiten als Indikationen für eine bilaterale Oophorektomie im späten 19. Jahrhundert. Dissertation, Med. Fakultät, Erlangen-Nürnberg

    Google Scholar 

  • Canuso CM, Goldstein JM, Wojcik J, Dawson R, Brandman D, Klibanski A, Schildkraut JJ, Green AI (2002) Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res 111: 11–20

    Article  PubMed  CAS  Google Scholar 

  • Choi SH, Kang SB, Joe SH (2001). Changes in premenstrual symptoms in women with schizophrenia: a prospective study. Psychosom Med 63: 822–829

    PubMed  CAS  Google Scholar 

  • Clouston S (1906) Clinical lectures on mental disease. London

    Google Scholar 

  • Cyr M, Carlon F, Morissette M, DiPaolo T (2002) Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson’s disease. J Psychiatry Neurosci 27: 12–27

    PubMed  Google Scholar 

  • DeLisi LE, Dauphinais ID, Hauser P (1989) Gender differences in the brain: are they relevant to the pathogenesis of schizophrenia? Compr Psychiatry 30: 197–208

    Article  PubMed  CAS  Google Scholar 

  • Diczfalusy E, Lauritzen C (1961) Östrogene beim Menschen. Springer, Berlin

    Google Scholar 

  • DiPaolo T (1994) Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5: 27–42

    CAS  Google Scholar 

  • Fink G, Sumner BEH, McQueen JK, Wilson H, Rosie R (1998) Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiology 25: 764–775

    CAS  Google Scholar 

  • Fink G, Sumner BEH, Rosie R, Grace O, Quinn JP (1996) Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16: 325–344

    Article  PubMed  CAS  Google Scholar 

  • Forrest AD, Hay AJ (1971) Sex differences and the schizophrenic experience. Acta Psychiatr Scand 47: 137–149

    PubMed  CAS  Google Scholar 

  • Garcia-Segura LM, Azcoitia I, DonCarlos LL (2001) Neuroprotection by estradiol. Progr Neurobiol 63: 29–60

    Article  PubMed  CAS  Google Scholar 

  • Gattaz WF, Vogel P, Riecher-Rössler A, Soddu G (1994) Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry 36: 137–139

    Article  PubMed  CAS  Google Scholar 

  • Georgi F, Fels E (1933) Follikelhormonbestimmungen im Harn schizophrener Frauen. Z Gesamte Neurol Psychiatrie 147: 746–756

    Google Scholar 

  • Glick J, Stewart D (1980) A new drug treatment for premenstrual exacerbation of schizophrenia. Compr Psychiatry 21: 281–287

    Article  PubMed  CAS  Google Scholar 

  • Gordon JH, Borison RL, Diamond BI (1980) Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 15: 389–396

    PubMed  CAS  Google Scholar 

  • Guy U (ed) (1976) ECDEU Assessmant manual for psychopharmacology, revised. DHEU Publication No. (ADM): 76–338. Rockville, National Institute of Mental Health

    Google Scholar 

  • Häffner R (1912) Beziehungen zwischen Menstruation und Nerven-und Geistes-krankheiten auf Grund der Literatur und klinischer Studien. Z Gesamte Neurol Psychiatrie 9: 154–223

    Google Scholar 

  • Häfner H, an der Heiden W, Behrens S, Gattaz F, Hambrecht M, Löffler W, Maurer K, Munk-Jørgensen P, Nowotny B, Riecher-Rössler A, Stein A (1998) Causes and consequences of the gender differences in age at onset of schizophrenia. Schizophr Bull 24: 99–113

    PubMed  Google Scholar 

  • Häfner H, Behrens S, De Vry J, Gattaz F (1991) Oestradiol enhences the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic neuro-transmission. Evidence from an epidemiological study and from animal experiments. Eur ArchPsychiatr Clin Neurosci 241: 65–68

    Google Scholar 

  • Häfner H, Riecher-Rössler A, Maurer K, Fätkenheuer B, Löffler W (1992) First onset and early symptomatology of schizophrenia. A chapter of epidemiologicyl and neurobiological research into age and sex differences. Eur Arch Psychiatr Clin Neurosci 242: 109–118

    Google Scholar 

  • Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37: 434–441

    PubMed  CAS  Google Scholar 

  • Hallonquist JD, Seeman MV, Lang M, Rector NA (1993) Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 33: 207–209

    Article  PubMed  CAS  Google Scholar 

  • Harris AH (1997) Menstrually related symptom changes in women with schizophrenia. Schizophr Res 27: 93–99

    PubMed  CAS  Google Scholar 

  • Hautzinger M, Bailer M, Worall H, Keller F (1995) Beck-Depressions-Inventar (BDI). Testhandbuch, 2nd ed. Huber, Bern

    Google Scholar 

  • Hegar A (1884) Castration als Mittel gegen nerv6se und psychische Leiden. Arch Gynäkologie 24: 318–323

    Google Scholar 

  • Hendrick V, Altshuler LL, Burt VK (1996) Course of psychiatric disorders across the menstrual cycle. Harvard Rev Psychiatry 4: 200–207

    CAS  Google Scholar 

  • Hoff AL, Kremen WS, Wieneke MH, Lauriello J, Blankfeld HM, Faustman WO, Csernansky JG, Nordahl TE (2001) Association of estrogen levels with neuro-psychological performance in women with schizophrenia. Am J Psychiatry 158: 1134–1139

    Article  PubMed  CAS  Google Scholar 

  • Huber TJ, Rollnik J, Wilhelms J, von zur Mühlen A, Emrich HM, Schneider U (2001) Estradiol levels in psychotic disorders. Psychoneuroendocrinology 26: 27–35

    Article  PubMed  CAS  Google Scholar 

  • Jolly Ph (1915) Menstruation und Psychose. Arch Psychiatrie Nervenkrankheiten 55: 637–686

    Google Scholar 

  • Kafka V (1935) Hormone bei Schizophrenie. Wien Med Wochenschr 85: 30–31

    Google Scholar 

  • Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261–276

    PubMed  CAS  Google Scholar 

  • Kendell RE, Chalmers JC, Platz C (1987) Epidemiology of puerperal psychoses. Br J Psychiatry 150: 662–673

    PubMed  CAS  Google Scholar 

  • Klinga K (1994) Determination of hormones and hormone receptors. In: Runnebaum B, Rabe T (eds) Gynecological endocrinology and reproductive medicine, vol 1. Springer, Berlin Heidelberg New York, 45–54

    Google Scholar 

  • König C, Linzenmeier G (1913) Ueber die Bedeutung gynäkologischer Erkrankungen und den Wert ihrer Heilung bei Psychosen. Arch Psychiatrie Nervenkrankheiten 51: 1002–1054

    Google Scholar 

  • Könnecke R, Häfner H, Maurer K, Löffler W, an der Heiden W (2000) Main risk factors for schizophrenia: increased familial loading and pre-and peri-natal complications antagonize the protective effect of oestrogen in women. Schizophr Res 44: 81–93

    PubMed  Google Scholar 

  • Kraepelin E (1909) Psychiatrie, Bd 1–4. Barth, Leipzig

    Google Scholar 

  • Krafft-Ebing R v (1878) Untersuchungen über das Irresein zur Zeit der Menstruation. Arch Psychiatrie Nervenkrankheiten 8: 65–107

    Google Scholar 

  • Krafft-Ebing R v (1903) Lehrbuch der Psychiatrie auf klinischer Grundlage für praktische Ärzte und Studierende, 7th ed. Ferd. Enke, Stuttgart

    Google Scholar 

  • Kretschmer E (1921) Körperbau und Charakter. Springer, Berlin

    Google Scholar 

  • Kulkarni J, DeCastella A, Riedel A, Taffe J, Fitzgerald P, Burger H (2001) Estrogen — a potential new treatment in schizophrenia. Schizophr Res 48: 137–144

    Article  PubMed  CAS  Google Scholar 

  • Kulkarni J, DeCastella A, Smith D, Taffe J, Keks N, Copolov D (1996) A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 20: 247–252

    Article  PubMed  CAS  Google Scholar 

  • Lansbury J, Hughes J (1939) Estrin excretion in psychotic patients. Am J Psychiatry 95: 1119–1125

    CAS  Google Scholar 

  • Lee SJ, McEwen BS (2001) Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41: 569–591

    PubMed  CAS  Google Scholar 

  • Leidenberger FA (1992) Klinische Endokrinologie für Frauenärzte. Berlin, Springer

    Google Scholar 

  • Lewine RRJ (1981) Sex differences in schizophrenia. Psychol Bull 90: 432–444

    PubMed  CAS  Google Scholar 

  • Lewine RRJ, Strauss JS, Gift TE (1981) Sex differences in age at first hospital admission for schizophrenia: a fact or artifact? Am J Psychiatry 138: 440–444

    PubMed  CAS  Google Scholar 

  • Lindamer LA, Buse DC, Lohr JB, Jeste DV (2001) Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry 49: 47–51

    Article  PubMed  CAS  Google Scholar 

  • Loranger AW (1984) Sex difference in age of onset of schizophrenia. Arch Gen Psychiatry 41: 157–161

    PubMed  CAS  Google Scholar 

  • Mahe V, Dumaine A (2001) Oestrogen withdrawal associated psychoses. Acta Psychiatr Scand 104: 323–331

    Article  PubMed  CAS  Google Scholar 

  • Mall G (1958) On the hormonal treatment of pre-and postmenstrual ovarian psychoses. In: Reiss M (ed) Psychoendocrinology. Grune & Stratton, Orlando, 96–103

    Google Scholar 

  • Mall G (1960) Diagnostik und Therapie ovarieller Psychosen. Zentralbl Gesamte Neurol Psychiatrie 155: 250

    Google Scholar 

  • Mayer CEL (1872) Menstruation im Zusammenhange mit psychischen Störungen. Beiträge zur Geburtshülfe und Gynäkologie 1: 111–135

    Google Scholar 

  • Mayer CEL (1869) Die Beziehungen der krankhaften Zustande in den Sexualorganen des Weibes zu Geistesstörungen. Berlin

    Google Scholar 

  • McEwen BS, Alvers SE (1999) Estrogen actions in the central nervous system. Endocrine Rev 20: 279–307

    Article  CAS  Google Scholar 

  • Melkersson KI, Hulting A-L, Rane AJ (2001) Dose requirement and prolactin elevation of anttipsychotics in male and female patients with schizophrenia or related psychoses. Br J Clin Pharmacol 51: 317–324

    Article  PubMed  CAS  Google Scholar 

  • Morissette M, DiPaolo T (1993) Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 58: 16–22

    PubMed  CAS  Google Scholar 

  • Nilsson P (1939) Der Prolan-und Follikulingehalt des Hams bei schizophrenen Frauen mit in der Genitalsphäre lokalisierten taktilen Halluzinationen. Upsala Läkareförenings Förhandlingar 44: 495–504

    CAS  Google Scholar 

  • Notman MT, Nadelson CC (2002). The hormone replacement therapy controversy. Arch Women Ment Health 5: 33–35.

    PubMed  CAS  Google Scholar 

  • Nott PN (1982). Psychiatric illness following childbirth in Southampton: a case register study. Psychol Med 12: 557–561

    PubMed  CAS  Google Scholar 

  • Oesterreicher W (1934) Die Ausscheidung des gonadotropen Hormons des Hypophy-senvorderlappens und des weiblichen Sexualhormons (Follikelhormon) bei Manien, Depressionen und Schizophrenien im geschlechtsreifen Alter. Wien Klin Wochenschr 46: 1385–1388

    Google Scholar 

  • Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Reports 10: 799–812

    Google Scholar 

  • Rabe T, Runnebaum B (1997) Hormones. In: Runnebaum B, Rabe T (eds) Gynecological endocrinology and reproductive medicine, vol 1. Springer, Heidelberg Berlin New York, 1–43

    Google Scholar 

  • Reiss M (ed) (1958) Psychoendocrinology. Grune & Stratton, Orlando

    Google Scholar 

  • Riecher-Rössler A (2003) Oestrogens and schizophrenia. Curr Opin Psychiatry 16: 187–192

    Google Scholar 

  • Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R (1994) Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20: 203–214

    PubMed  Google Scholar 

  • Ross SM (1909): Menstruation in its relationships to insanity. J Mental Sci 55: 270–280

    Google Scholar 

  • Sacerdoti G, Carry E (1955) Funzionalità epatica e reattivita cutanea agli estrogeni in schizofreniche con iperestrogenismo. Rivista di Patologia Nervosa e Mentale 76: 781–790

    PubMed  CAS  Google Scholar 

  • Saethre H (1933) Titrierung von Sexualhormonen bei Geisteskranken. Klin Wochenschr 12: 1409–1410

    CAS  Google Scholar 

  • Salokangas RR (1983) Prognostic implications of the sex of schizophrenic patients. Br J Psychiatry 142: 145–151

    Article  PubMed  CAS  Google Scholar 

  • Sartorius N, Jablensky A, Shapiro R (1978) Cross-cultural differences in the short-term prognosis of schizophrenic psychoses. Schizophr Bull 4: 102–113

    PubMed  CAS  Google Scholar 

  • Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, Day R (1986) Early manifestations and first-contact incidence of schizophrenia in different cultures. Psychol Med 16: 909–928

    Article  PubMed  CAS  Google Scholar 

  • Schaefer A (1894) Einfluss der Psychose auf den Menstruationsvorgang. Allg Z Psychiatrie Psychisch-gerichtliche Medizin 50: 976–996

    Google Scholar 

  • Schneider HPG (2002) The view of the International Menopause Society on the Women’s Health Initiative. Climacteric 5: 211–216

    PubMed  CAS  Google Scholar 

  • Schroeter R (1874) Die Menstruation in ihren Beziehungen zu den Psychosen. Z Psychiatrie 30: 551–572 (part 1); 31: 234–250 (part 2)

    Google Scholar 

  • Sears HA, Morter RA, Simonsen M, Williams C (1937) Blood estrin level in schizophrenia. Am J Psychiatry 93: 1293–1303

    Google Scholar 

  • Seeman MV (1997) Psychopathology in women and men: focus on female hormones. Am J Psychiatry 154: 1641–1647

    PubMed  CAS  Google Scholar 

  • Seeman MV (1996) The role of estrogen in schizophrenia. J Psychiatry Neurosci 21: 123–127

    PubMed  CAS  Google Scholar 

  • Seeman MV (1985) Sex and schizophrenia. Can J Psychiatry 30: 313–315

    PubMed  CAS  Google Scholar 

  • Seeman MV (1983) Interaction of sex, age, and neuroleptic dose. Compr Psychiatry 24: 125–128

    Article  PubMed  CAS  Google Scholar 

  • Seeman MV (1982) Gender differences in schizophrenia. Can J Psychiatry 27: 107–112

    PubMed  CAS  Google Scholar 

  • Smith S, Wheeler MJ, Murray R, O'Keane V (2002) The effects of antipsychotic induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol 22: 109–114

    Article  PubMed  CAS  Google Scholar 

  • Swanson DW, Barron A, Floren A, Smith JA (1964) The use of norethynodrel in psychotic females. Am J Psychiatry 120: 1101–1103

    PubMed  CAS  Google Scholar 

  • The North American Menopause Society (2003) Estrogen and progestogen use in peri-and postmenopausal women: September 2003 position statement of The North American Menopause Society. Menopause 10: 497–506

    Google Scholar 

  • Tsuang MT, Dempsey GM, Rauscher FA (1976) A study of "atypical schizophrenia": comparison with schizophrenia and affective disorder by sex, age of admission, precipitant, outcome, and family history. Arch Gen Psychiatry 33: 1157–1160

    Google Scholar 

  • Tukey JW (1977) Exploratory data analysis. Reading Mass., Addison-Wesley

    Google Scholar 

  • Turgeon JL, McDonnel DP, Martin KA, Wise PM (2004) Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304: 1269–1273

    Article  PubMed  CAS  Google Scholar 

  • Wells S (1886) Castration in mental and nervous diseases. A symposium by Sir T. Spencer Wells, Dr. Alfred Hegar and Robert Battey MD. Am J Med Sci 8: 455–471

    Google Scholar 

  • Writing Group for the Women’s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. J Am Med Assoc 288: 321–333

    Google Scholar 

  • Writing Group of the International Menopause Society Executive Committee (2004) Guidelines for the hormone treatment of women in the menopause transition and beyond. Climacteric 7: 8–11

    Google Scholar 

Download references

Authors
  1. Niels Bergemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christoph Mundt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Parzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Benno Runnebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Franz Resch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry, University of Heidelberg, Germany

    Niels Bergemann

  2. Psychiatric Outpatient Department, University of Basel, Switzerland

    Anita Riecher-Rössler

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag/Wien

About this chapter

Cite this chapter

Bergemann, N., Mundt, C., Parzer, P., Runnebaum, B., Resch, F. (2005). Hypoestrogenism and Estrogen Replacement Therapy in Women Suffering from Schizophrenia. In: Bergemann, N., Riecher-Rössler, A. (eds) Estrogen Effects in Psychiatric Disorders. Springer, Vienna. https://doi.org/10.1007/3-211-27063-9_6

Download citation

  • DOI: https://doi.org/10.1007/3-211-27063-9_6

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-40485-0

  • Online ISBN: 978-3-211-27063-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation